CODX Co Diagnostics Inc

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * BENSON REED L	2. Issuer Name and Ticker or Trading Symbol Co-Diagnostics, Inc. [ CODX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) CFO and Secretary
(Last)          (First)          (Middle) 2401 S. FOOTHILL DRIVE SUITE D	3. Date of Earliest Transaction (MM/DD/YYYY) 11/25/2020
(Street) SALT LAKE CITY, UT 84109 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/25/2020		M		100000	A	$1.10	100000	D
Common Stock	11/25/2020		F		10476 (2)	D	$1.10	89524	D
Common Stock	11/25/2020		S		89524 (3)	D	$10.50	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$1.10	11/25/2020 (1)		M			100000	(2)	9/2/2029	Common Stock	100000	$0.00	25000	D

Explanation of Responses:
(1)	Non-Qualified Stock Option granted to Reporting Person on September 3, 2019 pursuant to the Issuer's 2015 Long-Term Incentive Plan, as amended, to purchase up to 125,000 shares of common stock of the Issuer and previously reported on a Form 4 filed with the Commission on November 15, 2019.
(2)	100,000 of the Options have vested.
(3)	Reflects 10,476 shares withheld by the Issuer at the market price of $10.50 per share less the exercise price of $1.10 per share to fund the cashless exercise of 100,000 options owned by the Reporting Person.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
BENSON REED L 2401 S. FOOTHILL DRIVE SUITE D SALT LAKE CITY, UT 84109			CFO and Secretary

Signatures
/s/ Reed L. Benson		11/30/2020
**Signature of Reporting Person		Date